{{Rsnum
|rsid=4919743
|Gene=KRT8
|Chromosome=12
|position=52915800
|Orientation=minus
|GMAF=0.09366
|Gene_s=KRT8
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 77.9 | 18.6 | 3.5
| HCB | 97.0 | 3.0 | 0.0
| JPT | 98.2 | 1.8 | 0.0
| YRI | 70.7 | 27.2 | 2.0
| ASW | 73.7 | 24.6 | 1.8
| CHB | 97.0 | 3.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 90.6 | 9.4 | 0.0
| LWK | 67.6 | 29.6 | 2.8
| MEX | 78.9 | 21.1 | 0.0
| MKK | 81.3 | 18.1 | 0.6
| TSI | 72.3 | 25.7 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21960693
|Title=A genome-wide survey over the ChIP-on-chip identified androgen receptor binding genomic regions identifies a novel prostate cancer susceptibility locus at 12q13.13
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}